Jessica Hagen
The behavioral health-focused company will use the Series A funds to accelerate product development and expand support for its customer base.
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
The offering measures AI's real-world performance and safety around handling realistic medical conversations, using physician-created rubrics and GPT-4.1 scoring.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
The company's filing comes two months after fellow digital musculoskeletal care company Hinge Health filed for IPO.
The companies will integrate Sonde's voice-based health monitoring technology with Saaya's mental health platform to support large enterprises with blue-collar workers.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
Brad Smith is the third person in the world to receive Neuralink's brain-computer implant and the first person with ALS.
Project Stargate, an initiative to enhance U.S. AI infrastructure, is exploring international expansion, particularly in the UK.